Tag Archives: randomised trial
Semaglutide in MASH: What a 52-Week Biopsy Trial Found
Semaglutide plus an SGLT2 inhibitor beat monotherapy on every histological number in a 52-week MASH trial, and still missed its primary endpoints.
No account yet?
Create an AccountJoin the list for batch updates and new compound announcements. We will send you a single-use 8% code once you confirm your address.
Every batch is tested separately
Purity is measured per production lot, not once per product.
See the batch records